Bespoke Extracts (BSPK) Interest Expenses (2014 - 2025)
Bespoke Extracts (BSPK) reported Interest Expenses of $24197.0 for Q3 2025, up 84.08% on a YoY basis from $13145.0 in Q3 2024, and down 64.42% sequentially from $68000.0 in Q2 2025.
Bespoke Extracts (BSPK) Interest Expenses (2014 - 2025) Analysis & Trends
Bespoke Extracts (BSPK) has 12 years of Interest Expenses data on file, last reported at $24197.0 in Q3 2025.
- For the quarter ending Q3 2025, Interest Expenses rose 84.08% year-over-year to $24197.0; the trailing twelve-month figure through Sep 2025 stood at $210405.0 (up 435.59% YoY), and the FY2024 full-year result was $1.9 million, up 10.9% from the prior year.
- Interest Expenses slipped to $24197.0 in Q3 2025, from $68000.0 in the prior quarter.
- In the past five years, Interest Expenses ranged from a high of $1.2 million in Q3 2021 to a low of $4173.0 in Q4 2023.
- A 5-year average of $165662.8 and a median of $71957.5 in 2022 frame the typical range for Interest Expenses.
- Across the five-year window, Interest Expenses tumbled 99.01% in 2023 and surged 3791.95% in 2024, its largest moves.
- Tracing BSPK's Interest Expenses over 5 years: stood at $1.2 million in 2021, then tumbled by 64.63% to $421842.0 in 2022, then plunged by 99.01% to $4173.0 in 2023, then surged by 3791.95% to $162411.0 in 2024, then sank by 85.1% to $24197.0 in 2025.
- Business Quant data shows BSPK's Interest Expenses at $24197.0 in Q3 2025, $68000.0 in Q2 2025, and $80000.0 in Q1 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 88.07 Bn | 86.20 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.75 Bn | 32.01 Bn | 1.97 Bn | - |
| 3 | Zoetis | 31.84 Bn | 29.90 Bn | 1.62 Bn | 62.00 Mn |
| 4 | Takeda Pharmaceutical | 27.18 Bn | 23.12 Bn | 4.39 Bn | 944.51 Mn |
| 5 | United Therapeutics | 23.09 Bn | 20.93 Bn | 648.10 Mn | 1.77 Bn |
| 6 | RedHill Biopharma | 21.32 Bn | 21.32 Bn | - | - |
| 7 | Viatris | 19.96 Bn | 18.16 Bn | 1.16 Bn | 1.21 Bn |
| 8 | Neurocrine Biosciences | 17.66 Bn | 16.34 Bn | 800.70 Mn | 590.20 Mn |
| 9 | Elanco Animal Health | 12.44 Bn | 12.02 Bn | 785.00 Mn | 57.00 Mn |
| 10 | Bespoke Extracts | 1.12 Mn | 1.11 Mn | 234,175.00 | 24,197.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 24,197.00 |
| Sep 30, 2025 | 24,197.00 |
| Jun 30, 2025 | 68,000.00 |
| Jun 30, 2025 | 68,000.00 |
| Mar 31, 2025 | 80,000.00 |
| Mar 31, 2025 | 80,000.00 |
| Dec 31, 2024 | 162,411.00 |
| Dec 31, 2024 | 162,411.00 |
| Sep 30, 2024 | 13,145.00 |
| Sep 30, 2024 | 13,145.00 |
| Jun 30, 2024 | 10,652.00 |
| Jun 30, 2024 | 10,652.00 |
| Mar 31, 2024 | 11,315.00 |
| Mar 31, 2024 | 11,315.00 |
| Dec 31, 2023 | 4,173.00 |
| Dec 31, 2023 | 4,173.00 |
| Sep 30, 2023 | 79,380.00 |
| Sep 30, 2023 | 79,380.00 |
| Jun 30, 2023 | 37,800.00 |
| Jun 30, 2023 | 37,800.00 |